Facioscapulohumeral Muscular Dystrophy (FSHD) Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Study of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD)
Condition: Facioscapulohumeral Muscular Dystrophy Interventions: Drug: ACE-083; Drug: ACE-083 or placebo Sponsor: Acceleron Pharma, Inc. Not yet recruiting - verified October 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 5, 2016 Category: Research Source Type: clinical trials
Effects of NMES on Muscle Function of Patients With FSHD: a Double-blind Randomized Controled Clinical Trial
Condition: Primary Disease Facioscapulohumeral Dystrophy (FSHD) Interventions: Other: Current flow between sensory and motor threshold; Device: Current intensity upper of motor threshold by Kneehab XP technology Sponsor: University Hospital, Montpellier Recruiting - verified August 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 3, 2016 Category: Research Source Type: clinical trials
